Kolexia
Bouhnik Yoram Gastro-entérologie
Bouhnik Yoram
Gastro-entérologie
Cmc Ambroise Pare Hartmann Site 25
Neuilly-sur-Seine, France
368 Activités
1.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Sténose pathologique Ischémie Inflammation Ulcère

Collaborateurs

Voir plus
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Treton Xavier
Treton Xavier
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France
Stefanescu Carmen
Stefanescu Carmen
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France

Industries

Voir plus
Abbvie
180 collaboration(s)
Dernière en 2023
Janssen
66 collaboration(s)
Dernière en 2023
Pfizer
20 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
18 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
USTAP: USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Essai Clinique (Janssen)   18 janvier 2024
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Journal of Crohn's & colitis   18 octobre 2023
Tofacitinib for patients with anti-TNF refractory ulcerative proctitis: a multicenter cohort study from the GETAID.
Journal of Crohn's & colitis   05 octobre 2023
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review.
Clinical drug investigation   24 août 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
Journal of Crohn's & colitis   06 juillet 2023
Yoram Bouhnik - Maladies Inflammatoires Chroniques de l’Instestin, sur Objécif Santé
Youtube @ RADIO RCJ   21 juin 2023
The PERFUSE study: The experience of patients receiving Adalimumab biosimilar SB5.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   10 juin 2023
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment.
Inflammatory bowel diseases   02 juin 2023
CONTROL: An Open-label Randomized Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating adaLimumab: The CONTROL Trial
Essai Clinique (Abbvie)   30 mai 2023